Domatinostat
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Domatinostat, covering 2024-05-08 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma [Phase 1, Phase 2]